Autologous bone marrow-derived mesenchymal stem cells for liver cirhosis

This study aims to assess the safety and efficacy of combination therapy of Pioglitazone with infusion of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs), for the treatment of liver cirrhosis.